OPTN - multi bottom - upcoming catalystThis is not a financial advice!
Needs to break 2 level for further up move.
Most info on the chart.
Trade carefully!
OPTN trade ideas
OptiNose: Maximum OptimismGood afternoon.
I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company.
Summary:
Technical analysis:
On the chart, we can see the completion of corrective wave 2 and the emergence of impulse wave 3.
According to the RSI indicator, we can see an uptrend, which confirms the labeling of the Elliott waves.
On the 1D chart, we can see an open gap in the area of $6-7 per share.
Currently, the company's shares are in the area of the downtrend breakout. In addition, Optinose shares have broken through EMA 55 and are just below EMA 89.
Fundamental Analysis:
You can read a complete fundamental analysis of the company in my analytical article in SA.
Conclusion
Considering the above factors, I believe that the growth of Optinose shares will continue.
Disclosure:
This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sold securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.
OPTINOSE: "Rocket launch"Greetings
Summary:
Fundamental Analysis:
Full year 2020 XHANCE prescriptions increased 70% compared to full year 2019
Company expects top-line results from one of its clinical trials evaluating XHANCE as a potential treatment for Chronic Sinusitis by the end of 2021
In April 2021, the Company expects to initiate a randomized, proof of concept study in subjects who have tested positive for SARS-CoV-2 infection, are recently infected, and who have mild or no symptoms. This pilot study being conducted in Mexico will evaluate both the magnitude and duration of viral load reduction after a single dose of OPN-019. The Company expects top-line results from this study in second quarter 2021.
The company shows stable revenue growth from year to year.
Technical analysis:
From May 2020 to the end of June 2020, the 5th wave movement was completed.After that, a correction began.
At the moment, the company's shares are in the oversold zone according to the RSI indicator.
The company has several open gaps, namely in the following areas: $ 6-7, $ 10-11 per share.
At the moment, the company's shares are at a strong support level .
Disclosure: I am/we are long OPTN.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from TradingView). I have no business relationship with any company whose stock is mentioned in this article.
OPTN Technical Analysis 🧙OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhalation delivery system, to deliver a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.
If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
OPTN is one of the best stocks I have ever seen in a while.OPTN is one of the best stocks I have ever seen in a while.
OPTN Technical Analysis 🧙OptiNose Inc is a US-based specialty pharmaceutical company which focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, which utilizes proprietary breath powered exhalation delivery system, to deliver a topically-acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.
If you understand the idea,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
OPTN Follow Your Nose!OPTN risk to reward ratio looks phenomenal right now. We have horizontal price support, uptrend price support, horizontal RSI support, hidden bullish RSI divergence, and a recent gap fill. Based on the prior signals, I'm targeting +30% gain in less than 2 weeks to fill the gap at $6.40. This setup will be immediately invalidated if the price closes below support. Let's see what happens.
OPTN_PullbackUp over 3% today after a 5-day pullback. Watching for the uptrend to continue and retest the 8.00 resistance level.
$OPTN #OPTN Best of noted a #Chaikin Osc even so it lagging somewhat , but overall an opportunity if missed previously Note how SMA 20 in sight means SMA 100 door is open
Like to trade here long 30 -45 day as previous trade was very profitable imo
Good luck all !
